From: Anti-West Nile virus activity of in vitro expanded human primary natural killer cells
Days Post Treatments | 1 | 2 | 3 | 5 | 6 | 7 | 8 | 9 | 12 | 13 |
---|---|---|---|---|---|---|---|---|---|---|
Normal control | - | - | - | - | - | - | - | - | - | - |
WNV control | - | - | - | 2+ | 4+ | 4+ | 4+ | 4+ | 4+ | 4+ |
Control Sup 1:2 | - | - | - | 2+ | 3+ | 4+ | 4+ | 4+ | 4+ | 4+ |
NK Sup 1:2 | - | - | - | - | - | - | - | - | - | - |
NK Sup 1:2 + α IFN-αa | - | - | - | - | - | - | - | - | - | - |
NK Sup 1:2 + α IFN-βa | - | - | - | - | - | - | - | - | - | - |
NK Sup 1:2 + α IFN-γa | - | - | - | 1+ | 2+ | 3+ | 3+ | 4+ | 4+ | 4+ |